Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Antibody supplier Bioventix posted a 1% rise in annual profit amid rising sales of a vitamin D antibody to diagnostic companies.
Pre-tax profit for the year through June rose to £7.0m, up from £6.9m on-year.
Revenue rose 6% to 6% to £9.3m.
Bioventix declared a second interim dividend of 43p per share, up from 36p on-year, plus a special dividend of 47p per share, down from 55p on-year.
At 1:41pm: (LON:BVXP) Bioventix Plc share price was -175p at 3385p